This latency type 1 is sustained in many B-cell lymphomas including BL, DLBCL and terminally differentiated B-cell lymphomas, while in cHL and many NK- and T-cell lymphomas, virus-infected tumor cells express to a certain extent LMP1 and LMP2A&B (without EBNA2), known as latency type 2, and in lymphomas of immunosuppressed individuals EBNA2-3C are expressed along with LMPs, referred to as latency type 3 (116). Here, PDLIM7 is linked to B-cell non-Hodgkin lymphoma.